🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multi-model Image of Doxycycline in TAO

RecruitingNAAges 18 Years - 70 YearsAllSun Yat-sen University
NCT05112211 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Informed consent * Age 18-70 years old * Diagnosed with TAO Exclusion Criteria: * Sight-threatening TAO with dysthyroid optic neuropathy * Allergy of tetracycline * Have contraindications of MRI(metal pacemaker, fake teeth, foreign body and other materials which will disturb the examination)
💊

What it tests

  • Doxycycline Hyclate
📍

Where

1 site
Zhongshan Ophthalmic Center
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy